# Phase 2B Analysis Report

**Generated**: 2025-11-05T22:38:33.528888

## Executive Summary

- **Phase 2A**: 62/64 runs successful
- **Phase 2B**: 0/30 runs successful
- **Phase 2A Molecules**: 17
- **Phase 2B Molecules**: 0
- **Improvement**: -17 molecules

## Detailed Analysis

### Molecular Diversity

#### Formamide

- **Phase 2A**: 0 molecules
- **Phase 2B**: 0 molecules
- **Improvement**: 0 molecules

#### Hydrothermal

- **Phase 2A**: 8 molecules
- **Phase 2B**: 0 molecules
- **Improvement**: -8 molecules

#### Miller Urey

- **Phase 2A**: 9 molecules
- **Phase 2B**: 0 molecules
- **Improvement**: -9 molecules

## Recommendations

- [INSUFFICIENT] Molecular diversity still too low
- [ISSUE] Formamide scenario still inactive
- [ISSUE] Low completion rate
- [INCOMPLETE] PHASE 2 INCOMPLETE: Need more work

## Next Steps

1. Review analysis results
2. Generate publication figures
3. Proceed to Phase 3 (Paper Writing)
